Cypress Asset Management Inc Eli Lilly & CO Transaction History

Cypress Asset Management Inc

$357 Million
Q1 2024

A detailed history of Cypress Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Cypress Asset Management Inc holds 21,959 shares of LLY stock, worth $17.2 Million. This represents 4.78% of its overall portfolio holdings.

Number of Shares

21,959

Previous 22,289 1.48%

Holding current value

$17.2 Million

Previous $13 Million 31.49%

% of portfolio

4.78%

Previous 3.96%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 11, 2024	SELL	$592.2 - $792.28 $195,426 - $261,452	-330 Reduced 1.48%	21,959 $17.1 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $343,999 - $405,530	655 Added 3.03%	22,289 $13 Million
Q3 2023 Feb 09, 2024	SELL	$434.7 - $599.3 $258,646 - $356,583	-595 Reduced 2.67%	21,694 $11.7 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $115,744 - $154,763	-330 Reduced 1.5%	21,634 $10.1 Million
Q1 2023 May 25, 2023	SELL	$310.63 - $364.82 $192,901 - $226,553	-621 Reduced 2.75%	21,964 $7.54 Million
Q4 2022 Feb 28, 2023	SELL	$321.55 - $374.67 $300,649 - $350,316	-935 Reduced 3.98%	22,585 $8.26 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $92,798 - $105,753	-313 Reduced 1.31%	23,520 $7.61 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $16,723 - $19,636	-60 Reduced 0.25%	23,833 $7.73 Million
Q1 2022 Jun 06, 2022	SELL	$234.69 - $291.66 $919,515 - $1.14 Million	-3,918 Reduced 14.09%	23,893 $6.84 Million
Q4 2021 Jan 31, 2022	SELL	$224.85 - $279.04 $104,330 - $129,474	-464 Reduced 1.64%	27,811 $7.68 Million
Q3 2021 Oct 18, 2021	SELL	$221.6 - $272.71 $37,672 - $46,360	-170 Reduced 0.6%	28,275 $6.53 Million
Q2 2021 Aug 06, 2021	SELL	$180.55 - $233.54 $64,817 - $83,840	-359 Reduced 1.25%	28,445 $6.53 Million
Q1 2021 Apr 22, 2021	SELL	$164.32 - $212.72 $111,408 - $144,224	-678 Reduced 2.3%	28,804 $5.38 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $28,309 - $37,460	-217 Reduced 0.73%	29,482 $4.98 Million
Q3 2020 Oct 26, 2020	SELL	$146.22 - $169.13 $43,134 - $49,893	-295 Reduced 0.98%	29,699 $4.4 Million
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $90,719 - $109,179	-665 Reduced 2.17%	29,994 $4.92 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $9,047 - $11,198	76 Added 0.25%	30,659 $4.25 Million
Q4 2019 Feb 06, 2020	SELL	$106.92 - $132.43 $259,281 - $321,142	-2,425 Reduced 7.35%	30,583 $4.02 Million
Q3 2019 Oct 21, 2019	SELL	$106.79 - $116.16 $120,352 - $130,912	-1,127 Reduced 3.3%	33,008 $3.69 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $130,842 - $152,726	-1,181 Reduced 3.34%	34,135 $3.78 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $416,744 - $490,538	-3,744 Reduced 9.59%	35,316 $4.58 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $307,639 - $344,649	-2,905 Reduced 6.92%	39,060 $4.52 Million
Q3 2018 Oct 19, 2018	BUY	$85.86 - $107.31 $153,260 - $191,548	1,785 Added 4.44%	41,965 $4.5 Million
Q2 2018 Jul 27, 2018	SELL	$75.7 - $86.88 $371,687 - $426,580	-4,910 Reduced 10.89%	40,180 $3.43 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $1.24 Million - $1.47 Million	-16,776 Reduced 27.12%	45,090 $3.49 Million
Q4 2017 Jan 31, 2018	SELL	$81.94 - $87.89 $478,529 - $513,277	-5,840 Reduced 8.63%	61,866 $5.23 Million
Q3 2017 Nov 08, 2017	BUY	$77.07 - $85.54 $5.22 Million - $5.79 Million	67,706	67,706 $5.79 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Asset Management Inc with notifications on news.

Account

Cypress Asset Management Inc Eli Lilly & CO Transaction History